Mixed Topics
From the Journals
B-cell cancers: Sparse insight into preventing infections
Doctors treating CLL and other B-cell cancers are blindsided by a lack of research into acquired hypogammaglobulinemia prophylactics.
Feature
Dabigatran recalled over potential carcinogen
The nationwide recall is because of the detection of the nitrosamine impurity, N-nitroso-dabigatran.
From the Editor
Financial navigators saved about $2,500 per cancer patient
Partnering with financial navigators helped blood cancer patients sort through complex medical expenses and save money, a study showed.
Livin' on the MDedge
The air up there: Oxygen could be a bit overrated
Plus: Assume the position … for sleeping, and COVID’s connection to UFO sightings.
Feature
Increased cancer in military pilots and ground crew: Pentagon
But military aircrew and ground crew were less likely to die from cancer, compared with the U.S. population.
Latest News
Physician suicide: Investigating its prevalence and cause
“From your first day of medical school and throughout your career, there was a very rigid system in place that is quite unforgiving, is quite...
Livin' on the MDedge
The human-looking robot therapist will coach your well-being now
Plus: The mother of all mindsets and a colon named Collin.
Latest News
Silicone-based film for radiation dermatitis: It works, so why isn’t it used?
Use of the film significantly reduced the incidence of grade 2 or 3 radiation dermatitis in a study of women with breast cancer.
From the Journals
Erythema extent predicts death in cutaneous GVHD
Study: Extent of skin erythema correlates with deaths from graft-versus-host disease in blood cancer patients after stem cell transplants.
From the Journals
Venetoclax shows promise for r/r hairy cell leukemia
Italian study suggests benefits of administering venetoclax for patients with r/r cases of hairy cell leukemia, a rare blood cancer,
Feature
Cancer clinical trials: Can industry stack the deck?
Experts: New research into age disparities in cancer drug trials finds participants “markedly younger” than intended patient populations.